These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3460520)

  • 1. Synthesis and antibacterial activities of optically active ofloxacin.
    Hayakawa I; Atarashi S; Yokohama S; Imamura M; Sakano K; Furukawa M
    Antimicrob Agents Chemother; 1986 Jan; 29(1):163-4. PubMed ID: 3460520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ethylenediaminetetraacetic acid and gentamicin on the antibacterial activity of pyridone carboxylic acid derivatives against gram-negative bacilli.
    Miyake Y; Mitsui K; Suginaka H
    J Antimicrob Chemother; 1986 Mar; 17(3):327-32. PubMed ID: 3084441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H- pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin).
    Mitscher LA; Sharma PN; Chu DT; Shen LL; Pernet AG
    J Med Chem; 1987 Dec; 30(12):2283-6. PubMed ID: 2824776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antibacterial activities of optically active ofloxacin and its fluoromethyl derivative.
    Atarashi S; Yokohama S; Yamazaki K; Sakano K; Imamura M; Hayakawa I
    Chem Pharm Bull (Tokyo); 1987 May; 35(5):1896-902. PubMed ID: 3664798
    [No Abstract]   [Full Text] [Related]  

  • 5. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycoplasmal activity of ofloxacin (DL-8280).
    Osada Y; Ogawa H
    Antimicrob Agents Chemother; 1983 Mar; 23(3):509-11. PubMed ID: 6573869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-antibiotic effect induced by ofloxacin in both gram-positive and gram-negative bacteria.
    Reina S; Cavallero A; Debbia E
    Chemioterapia; 1988 Feb; 7(1):29-32. PubMed ID: 3163941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo activity of DL-8280, a new oxazine derivative.
    Sato K; Matsuura Y; Inoue M; Une T; Osada Y; Ogawa H; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Oct; 22(4):548-53. PubMed ID: 6960805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of possible metabolites of 1-cyclopropyl-1,4-dihydro-6-fluoro-5-methyl-7-(3-methyl-1-piperazinyl)- 4-oxo-3-quinolinecarboxylic acid (Grepafloxacin, OPC-17116).
    Morita S; Otsubo K; Matsubara J; Ohtani T; Kawano Y; Ohmori K; Ohguro K; Uchida M
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2246-52. PubMed ID: 8582026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolonecarboxylic acids. 2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acids.
    Cecchetti V; Fravolini A; Fringuelli R; Mascellani G; Pagella P; Palmioli M; Segre G; Terni P
    J Med Chem; 1987 Mar; 30(3):465-73. PubMed ID: 3820216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.
    Chau PY; Leung YK; Ng WW
    Infection; 1986; 14 Suppl 4():S237-9. PubMed ID: 3469153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of DR-3355, an optically active ofloxacin.
    Une T; Fujimoto T; Sato K; Osada Y
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1336-40. PubMed ID: 3195996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New "ofloxacin" type antibacterial agents. Incorporation of the spiro cyclopropyl group at N-1.
    Kiely JS; Schroeder MC; Sesnie JC
    J Med Chem; 1988 Oct; 31(10):2004-8. PubMed ID: 3172136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and identification of metabolites of ofloxacin in rats, dogs and monkeys.
    Sudo K; Okazaki O; Tsumura M; Tachizawa H
    Xenobiotica; 1986 Aug; 16(8):725-32. PubMed ID: 3464137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
    Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antibacterial activities of substituted 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acids.
    Hayakawa I; Hiramitsu T; Tanaka Y
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4907-13. PubMed ID: 6534539
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and antibacterial activity of thiazolopyrazine-incorporated tetracyclic quinolone antibacterials.
    Inoue Y; Kondo H; Taguchi M; Jinbo Y; Sakamoto F; Tsukamoto G
    J Med Chem; 1994 Mar; 37(5):586-92. PubMed ID: 8126698
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.